Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation

J Rheumatol. 2012 Aug;39(8):1500-2. doi: 10.3899/jrheum.120649.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Infliximab
  • Male

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab